Menu
Search
|

Menu

Close
X

Kitov Pharma Ltd KTOV.OQ (NASDAQ Stock Exchange Capital Market)

2.60 USD
-0.04 (-1.52%)
As of Feb 22
chart
Previous Close 2.64
Open 2.62
Volume 2,640
3m Avg Volume 55,481
Today’s High 2.62
Today’s Low 2.59
52 Week High 3.41
52 Week Low 1.27
Shares Outstanding (mil) --
Market Capitalization (mil) --
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 1 analysts

KEY STATS

Revenue
No Data Available
FY
-
FY
-
FY
-
FY
-
EPS
No Data Available
FY
-
FY
-
FY
-
FY
-

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.90
Price to Sales (TTM)
vs sector
--
5.77
Price to Book (MRQ)
vs sector
--
5.41
Price to Cash Flow (TTM)
vs sector
--
23.42
Total Debt to Equity (MRQ)
vs sector
--
16.52
LT Debt to Equity (MRQ)
vs sector
--
12.22
Return on Investment (TTM)
vs sector
--
14.43
Return on Equity (TTM)
vs sector
--
16.13

EXECUTIVE LEADERSHIP

John Waymack
Chairman of the Board & Chief Medical Officer, Since 2013
Salary: --
Bonus: --
Itzhak Israel
Chief Executive Officer, Director, Since 2012
Salary: --
Bonus: --
Simcha Rock
Chief Financial Officer, Director, Since 2013
Salary: --
Bonus: --
Gil Ben-Menachem
Vice President - Business Development, Since 2016
Salary: --
Bonus: --
Yisrael Gewirtz
Internal Auditor, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

One Azrieli Center, Round Buildi
TEL AVIV-YAFO     670110

Phone: +9723.9333121

Kitov Pharma Ltd, formerly Kitov Pharmaceuticals Holdings Ltd, is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

SPONSORED STORIES